Press Enter or Space to select a product option
But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response
Multi-System Reach Beyond the gut, BPC-157 has preclinical evidence across tendons, ligaments, muscles, bone, the liver, and the nervous system
Best Peptide for Tendonitis BPC-157 is commonly associated with tendon healing and is one of the most popular peptides explored for tendon-related concerns
Each of these side effects is temporary and improve gradually over time
Yet, in the three-plus decades since BPC-157 was discovered, no controlled human trial of the peptide has ever been published
